NME
CELG

Notis-McConarty Edward’s Celgene Corp CELG Stock Holding History

Notis-McConarty Edward’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-11,620
Closed -$1.15M – 102
2019
Q3 		$1.15M Sell
11,620
-3,087
-21% -$293K 0.54% 51
2019
Q2 		$1.36M Sell
14,707
-6,900
-32% -$655K 0.64% 48
2019
Q1 		$2.04M Hold
21,607
– – 0.98% 31
2018
Q4 		$1.38M Buy
21,607
+943
+5% +$69.6K 0.76% 42
2018
Q3 		$1.85M Buy
20,664
+275
+1% +$24.3K 0.99% 31
2018
Q2 		$1.62M Buy
20,389
+1,111
+6% +$92.2K 0.96% 30
2018
Q1 		$1.72M Buy
19,278
+778
+4% +$74.7K 1.03% 30
2017
Q4 		$1.93M Buy
18,500
+100
+0.5% +$11.3K 1.11% 29
2017
Q3 		$2.68M Buy
18,400
+100
+0.5% +$13.6K 1.68% 23
2017
Q2 		$2.38M Sell
18,300
-1,000
-5% -$123K 1.54% 24
2017
Q1 		$2.4M Sell
19,300
-300
-2% -$35.9K 1.58% 23
2016
Q4 		$2.27M Hold
19,600
– – 1.56% 22
2016
Q3 		$2.05M Hold
19,600
– – 1.4% 26
2016
Q2 		$1.93M Sell
19,600
-370
-2% -$38.3K 1.36% 27
2016
Q1 		$2M Hold
19,970
– – 1.42% 26
2015
Q4 		$2.39M Hold
19,970
– – 1.71% 20
2015
Q3 		$2.16M Sell
19,970
-500
-2% -$62K 1.61% 20
2015
Q2 		$2.37M Sell
20,470
-1,320
-6% -$151K 1.6% 24
2015
Q1 		$2.51M Sell
21,790
-500
-2% -$59.7K 1.74% 19
2014
Q4 		$2.49M Hold
22,290
– – 1.71% 23
2014
Q3 		$2.11M Buy
22,290
+2,280
+11% +$206K 1.49% 28
2014
Q2 		$1.72M Hold
20,010
– – 1.14% 32
2014
Q1 		$1.4M Hold
20,010
– – 0.97% 36
2013
Q4 		$1.69M Buy
+20,010
New +$1.58M 1.19% 30

Other funds holding CELG

FP
Factorial Partners Mt. Kisco, New York $138M AUM 25.59% 1-Year Est. Return
HCM
Howard Capital Management Roswell, Georgia $6.11B AUM 33.56% 1-Year Est. Return
PCMC
Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return
WCG
Weaver Consulting Group Huntington Beach, California $420M AUM 14.29% 1-Year Est. Return

Notis-McConarty Edward's CELG Position: Q4 2019 in Review

Notis-McConarty Edward sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 11,620 shares — an estimated $1.15M sold.

Notis-McConarty Edward first reported a position in CELG in Q4 2013 and held it in 24 quarters. The position peaked at $2.68M in Q3 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Notis-McConarty Edward reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Notis-McConarty Edward sold 11,620 Celgene Corp shares in Q4 2019, an estimated $1.15M.
  • Notis-McConarty Edward first reported a position in Celgene Corp in Q4 2013 and held it in 24 quarters.
  • Notis-McConarty Edward's Celgene Corp position peaked at $2.68M in Q3 2017.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Notis-McConarty Edward's 13F filing for Q4 2019, filed 15 Jan 2020.